CUBN and infection: Assuming that PID patients under appropriate IgG substitution therapy would still have local immunodeficiency in the upper and conductive airways, we hypothesised that protection of these areas of the respiratory tract might be best achieved by direct topical application of Igs to increase the Ig concentration at the site of infection.